5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole

Catalog No. :
ACNTWY034
CAS No. :
2641339-89-9
Molecular Formula :
C11H16BF3N2O2
Molecular Weight :
276.07

IUPAC Name:5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole

5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$639.00Login to see priceInquiryInquiry
250mg98%$1022.00Login to see priceInquiryInquiry
500mg98%$1703.00Login to see priceInquiryInquiry
1g98%$2554.00Login to see priceInquiryInquiry
5g98%$7661.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole
IUPAC Name5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole
Molecular FormulaC11H16BF3N2O2
Molecular Weight276.07
SMILESCC1=C(B2OC(C)(C)C(C)(C)O2)C(=NN1)C(F)(F)F
InChI KeyXKPDUDFMDUOCGL-UHFFFAOYSA-N
Synonym1H-Pyrazole, 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)-
CAS No.2641339-89-9

Synthetic Route by SureRoute

1. ACNTWY034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNTWY034 route product structure diagram
    ACNTWY0342641339-89-9
Inquiry

2. ACNTWY034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACXENK043 route compound structure diagram
    ACXENK04360061-68-9 In Stock
  4. Then
  5. ACNTWY034 route product structure diagram
    ACNTWY0342641339-89-9
Inquiry

Comments (0)